JP2024532261A5 - - Google Patents
Info
- Publication number
- JP2024532261A5 JP2024532261A5 JP2024512004A JP2024512004A JP2024532261A5 JP 2024532261 A5 JP2024532261 A5 JP 2024532261A5 JP 2024512004 A JP2024512004 A JP 2024512004A JP 2024512004 A JP2024512004 A JP 2024512004A JP 2024532261 A5 JP2024532261 A5 JP 2024532261A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- acid molecule
- molecule according
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2021/047207 | 2021-08-23 | ||
| USPCT/US2021/047207 | 2021-08-23 | ||
| US202263310042P | 2022-02-14 | 2022-02-14 | |
| US63/310,042 | 2022-02-14 | ||
| PCT/US2022/075187 WO2023028441A1 (en) | 2021-08-23 | 2022-08-19 | Engineered itr sequences and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532261A JP2024532261A (ja) | 2024-09-05 |
| JP2024532261A5 true JP2024532261A5 (cg-RX-API-DMAC7.html) | 2025-08-26 |
Family
ID=91165652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512004A Pending JP2024532261A (ja) | 2021-08-23 | 2022-08-19 | 操作itr配列および使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240350671A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4392444A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532261A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118103393A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023028441A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020001593A (es) | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
| JP7602454B2 (ja) | 2018-08-09 | 2024-12-18 | バイオベラティブ セラピューティクス インコーポレイテッド | 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用 |
| JP2025525583A (ja) | 2022-07-19 | 2025-08-05 | ランパート バイオサイエンス インコーポレイテッド | 非免疫原性環状非ウイルス性dnaベクター |
| CN120981563A (zh) * | 2023-03-24 | 2025-11-18 | 南京金斯瑞生物科技有限公司 | 一种提升质粒稳定性的宿主细胞 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014251099B2 (en) * | 2013-04-08 | 2019-01-17 | The University Of Kansas | Chimeric adeno-associated virus/ bocavirus parvovirus vector |
| KR20180118659A (ko) | 2016-02-01 | 2018-10-31 | 바이오버라티브 테라퓨틱스 인크. | 최적화된 viii 인자 유전자 |
| US11142775B2 (en) * | 2017-01-13 | 2021-10-12 | University Of Iowa Research Foundation | Bocaparvovirus small noncoding RNA and uses thereof |
| MX2020001593A (es) * | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
| JP7602454B2 (ja) | 2018-08-09 | 2024-12-18 | バイオベラティブ セラピューティクス インコーポレイテッド | 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用 |
-
2022
- 2022-08-19 JP JP2024512004A patent/JP2024532261A/ja active Pending
- 2022-08-19 EP EP22786219.0A patent/EP4392444A1/en active Pending
- 2022-08-19 CN CN202280068810.3A patent/CN118103393A/zh active Pending
- 2022-08-19 WO PCT/US2022/075187 patent/WO2023028441A1/en not_active Ceased
-
2024
- 2024-02-13 US US18/440,712 patent/US20240350671A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111492056B (zh) | 用于细胞的遗传修饰的非整合型dna载体 | |
| JP2025113389A (ja) | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス | |
| JP2022517174A5 (cg-RX-API-DMAC7.html) | ||
| JP7795357B2 (ja) | Fviii治療薬を発現するための非ウイルス性dnaベクターおよびその使用 | |
| US10047365B2 (en) | Replicative minicircle vectors with improved expression | |
| JP7583732B2 (ja) | フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用 | |
| EP2169072A1 (en) | Multiple RNA polymerase III promoter expression constructs | |
| JP2024534124A5 (cg-RX-API-DMAC7.html) | ||
| JP2022520803A (ja) | 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節 | |
| US20220184231A1 (en) | Closed-ended dna (cedna) and immune modulating compounds | |
| US7094399B2 (en) | Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses | |
| IL296660A (en) | Non-viral DNA vectors and their use for therapeutic expression of factor ix | |
| CA3186894A1 (en) | Tandem anellovirus constructs | |
| US20100203627A1 (en) | Long-term in vivo transgene expression | |
| JP2024501287A (ja) | RNAを閉じ込めたアネロウイルス(Anellovirus)キャプシドのインビトロアセンブリ | |
| US20240026374A1 (en) | Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) | |
| WO2024083095A1 (zh) | 环状rna及载体和载体的应用 | |
| US20230383311A1 (en) | Non-viral dna vectors and uses thereof for expressing fviii therapeutics | |
| WO2022068884A1 (zh) | 核酸递送方法及系统 | |
| TWI903434B (zh) | 具有改良負載基因表現率及降低基因毒性之腺相關病毒之經修飾複合體平台 | |
| CN114391040A (zh) | 用于调节载脂蛋白b(apob)基因表达的组合物和方法 | |
| IL325131A (en) | RNAi targeting KIF1A missense mutations for the treatment of KIF1A-related neurological disorder | |
| EP4008785A1 (en) | Circular nucleic acids and uses thereof for interfering with genome expression and proliferation of coronaviruses | |
| CN108517335A (zh) | 一种肝细胞miR-199b低表达的慢病毒表达载体及其构建方法 | |
| WO2025065890A1 (zh) | 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用 |